rdf:type |
|
lifeskim:mentions |
umls-concept:C0024485,
umls-concept:C0194810,
umls-concept:C0205210,
umls-concept:C0302891,
umls-concept:C0332305,
umls-concept:C0600139,
umls-concept:C1301732,
umls-concept:C1522609,
umls-concept:C1554112,
umls-concept:C1979874,
umls-concept:C2349975
|
pubmed:issue |
7
|
pubmed:dateCreated |
2001-8-21
|
pubmed:abstractText |
To assess the clinical value of MRI with and without contrast agent in the staging of prostatic carcinoma. Relevance for surgical management.
|
pubmed:language |
ger
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1438-9029
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
173
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
595-600
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11512230-Aged,
pubmed-meshheading:11512230-Contrast Media,
pubmed-meshheading:11512230-Gadolinium DTPA,
pubmed-meshheading:11512230-Humans,
pubmed-meshheading:11512230-Image Enhancement,
pubmed-meshheading:11512230-Magnetic Resonance Imaging,
pubmed-meshheading:11512230-Male,
pubmed-meshheading:11512230-Neoplasm Staging,
pubmed-meshheading:11512230-Predictive Value of Tests,
pubmed-meshheading:11512230-Prostate,
pubmed-meshheading:11512230-Prostate-Specific Antigen,
pubmed-meshheading:11512230-Prostatectomy,
pubmed-meshheading:11512230-Prostatic Neoplasms
|
pubmed:year |
2001
|
pubmed:articleTitle |
[Clinical value of native and contrast enhanced MRI in staging prostatic carcinoma before planned radical prostatectomy].
|
pubmed:affiliation |
Abt. für Diagnostische Radiologie, Allgemeines Krankenhaus, Hamburg.
|
pubmed:publicationType |
Journal Article,
English Abstract
|